Mockler Henk
Paragangliomas and pheochromocytomas are rare neuroendocrine tumors originating from the chromaffin cells of the sympathetic and parasympathetic nervous systems, respectively. While traditionally managed through surgical resection and adjuvant therapies, the advent of precision medicine has revolutionized the approach to diagnosing, treating, and managing these tumors. This article explores the evolving landscape of treatment modalities for paragangliomas and pheochromocytomas in the era of precision medicine.
இந்தக் கட்டுரையைப் பகிரவும்
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 